CA
SRPT icon

Commerzbank Aktiengesellschaft’s Sarepta Therapeutics SRPT Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-521,068
Closed -$11M – 1192
2014
Q3 		$11M Buy
521,068
+254,519
+95% +$5.74M 0.04% 290
2014
Q2 		$7.94M Sell
266,549
-70,565
-21% -$2.23M 0.04% 327
2014
Q1 		$8.1M Buy
337,114
+101,343
+43% +$2.58M 0.03% 308
2013
Q4 		$5.75M Buy
+235,771
New +$7.01M 0.03% 415
2013
Q3 		– Sell
-6,764
Closed -$257K – 1410
2013
Q2 		$257K Buy
+6,764
New +$242K ﹤0.01% 1301

Other funds holding SRPT

CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Commerzbank Aktiengesellschaft's SRPT Position: Q4 2014 in Review

Commerzbank Aktiengesellschaft sold out of Sarepta Therapeutics (SRPT) in Q4 2014, closing a stake of 521,068 shares — an estimated $11M sold.

Commerzbank Aktiengesellschaft first reported a position in SRPT in Q2 2013 and held it in 5 quarters. The position peaked at $11M in Q3 2014. 120 funds tracked by Wall St. Rank hold SRPT as of Q4 2014.

  • Commerzbank Aktiengesellschaft reported no remaining Sarepta Therapeutics position as of Q4 2014 after selling out during the quarter.
  • Commerzbank Aktiengesellschaft sold 521,068 Sarepta Therapeutics shares in Q4 2014, an estimated $11M.
  • Commerzbank Aktiengesellschaft first reported a position in Sarepta Therapeutics in Q2 2013 and held it in 5 quarters.
  • Commerzbank Aktiengesellschaft's Sarepta Therapeutics position peaked at $11M in Q3 2014.
  • 120 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q4 2014.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q4 2014, filed 5 Feb 2015.